Much of the work on nuclear lamins during the past 15 years has focused on mutations in LMNA (the gene for prelamin A and lamin C) that cause particular muscular dystrophy, cardiomyopathy, partial lipodystrophy, and progeroid syndromes. These disorders, often called "laminopathies," mainly affect mesenchymal tissues (e.g., striated muscle, bone, and fibrous tissue). Recently, however, a series of papers have identified important roles for nuclear lamins in the central nervous system. Studies of knockout mice uncovered a key role for B-type lamins (lamins B1 and B2) in neuronal migration in the developing brain. Also, duplications of LMNB1 (the gene for lamin B1) have been shown to cause autosome-dominant leukodystrophy. Finally, recent studies have uncovered a peculiar pattern of nuclear lamin expression in the brain. Lamin C transcripts are present at high levels in the brain, but prelamin A expression levels are very low-due to regulation of prelamin A transcripts by microRNA 9. This form of prelamin A regulation likely explains why "prelamin A diseases" such as Hutchinson-Gilford progeria syndrome spare the central nervous system. In this review, we summarize recent progress in elucidating links between nuclear lamins and neurobiology.T he nuclear lamina has attracted considerable scrutiny from biochemists, cell biologists, and geneticists. Much of this attention has been stimulated by the discovery that mutations in LMNA (the gene for the A-type lamins, prelamin A and lamin C) cause multiple human diseases, including muscular dystrophy, cardiomyopathy with conduction system disease, partial lipodystrophy, and progeroid syndromes (1-3). These diseases, often called "laminopathies," are largely confined to mesenchymal tissues. For the past decade, many laboratories have worked to define disease mechanisms and to devise therapeutic strategies. These efforts have been summarized in many reviews (2-11).While "LMNA diseases" have attracted most of the research efforts, a new topic has slowly emerged in the field-nuclear lamin biology in the brain. Three lines of investigation have contributed to the emergence of this topic. The first was work by developmental biologists that uncovered a role for the B-type lamins (lamins B1 and B2) in neuronal migration in the developing brain (12)(13)(14). The second was work showing that a demyelinating disorder, autosomal dominant leukodystrophy, is caused by LMNB1 gene duplications (15, 16). The third was work by clinical investigators to understand the spectrum of disease phenotypes in children with Hutchinson-Gilford progeria syndrome (17, 18), a precocious aging syndrome caused by a toxic form of prelamin A (19). For years, the field marveled that children with progeria have multisystem aging-like phenotypes but are spared common features of physiologic aging in the central nervous system, notably, senile dementia. Recent studies have identified a likely mechanismregulation of prelamin A by a brain-specific microRNA (17, 18).
PROTEINS OF THE NUCLEAR LAMINAThe nuclear lamina...